Nrf2 Modulation by Natural Compounds in Aging, Neurodegeneration, and Neuropathic Pain
This review summarizes the role of nuclear factor erythroid 2-related factor 2 (Nrf2) as a common link between aging, neurodegeneration, and neuropathic pain. Aging is characterized by oxidative stress and constant inflammation, which coincides with reduced Nrf2 activity and weaker antioxidant responses, increasing vulnerability to diseases. In neurodegenerative disorders-including Alzheimer's, Parkinson's, Huntington's disease, and amyotrophic lateral sclerosis-evidence indicates that impaired Nrf2 signaling contributes to oxidative damage, neuroinflammation, and mitochondrial dysfunction. Furthermore, in neuropathic pain, similar mechanisms are involved, and Nrf2 could play a role as a potential analgesic target because of its role in regulating cellular defense pathways. We also review natural Nrf2 modulators (e.g., flavonoids, other polyphenols, terpenoids, alkaloids), discussing their benefits alongside common translational limitations such as poor solubility, low oral bioavailability, rapid metabolism, and potential safety issues, including possible pro-oxidant effects and chemoresistance. We also outline future directions that should prioritize improving delivery systems, addressing <i>NRF2/KEAP1</i> gene variations, evaluating combinations with standard therapies, exploring preventive applications, and defining dosing, treatment duration, and long-term safety. Overall, current evidence indicates that Nrf2 modulation is a practical, cross-cutting approach relevant to healthy aging and disease management.
Authors
- Kęstutis Petrikonis (ORCID: https://orcid.org/0000-0002-6258-5767)
- Sergio Davinelli (ORCID: https://orcid.org/0000-0003-2578-7199)
- Dalia M. Kopustinskienė (ORCID: https://orcid.org/0000-0002-3399-2849)
- Jurga Bernatonienė (ORCID: https://orcid.org/0000-0003-1744-2932)
- Luciano Saso (ORCID: https://orcid.org/0000-0003-4530-8706)
- Alessandro Medoro (ORCID: https://orcid.org/0000-0002-6285-607X)
- Roberto Casale (ORCID: https://orcid.org/0000-0001-7708-5303)
Institutions
- University of Molise (IT)
- Lithuanian University of Health Sciences (LT)
- Ospedaliera di Piacenza (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3390/pharmaceutics18010118
- Primary Topic
- Genomics, phytochemicals, and oxidative stress
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lietuvos Mokslo Taryba